Results 121 to 130 of about 4,478 (181)

Nodal maximum standardised uptake value improves PSMA‐PET/CT‐based nodal staging in intermediate‐ and high‐risk prostate cancer

BJU International, Volume 138, Issue 1, Page 133-143, July 2026.
Objectives To evaluate whether nodal maximum standardised uptake value (SUVmax) improves the positive predictive value (PPV) of prostate‐specific membrane antigen (PSMA) positron emission tomography (PET)/computerised tomography (CT) for detecting lymph node invasion (LNI) in prostate cancer (PCa), and to develop clinical decision tools to guide ...
Alexandra S. Bruins Slot, Vera Sweere, Joris G. Heetman, Rick Hermsen, Lieke Wever, Jules Lavalaye, Maarten Vinken, Clinton D. Bahler, Mark Tann, Claudia Kesch, Tugce Telli, Wolfgang P. Fendler, Peter Ka‐Fung Chiu, Kwan Kit Wu, Fabio Zattoni, Laura Evangelista, Francesco Ceci, Marcin Miszczyk, Pawel Rajwa, Akihiro Matsukawa, Tamás Fazekas, Francesco Barletta, Alberto Briganti, Francesco Montorsi, Giorgio Gandaglia, Jean‐Paul A. Van Basten, Harm H. E. Van Melick, Roderick C. N. Van den Bergh, Giancarlo Marra, Timo F. W. Soeterik, Matthijs J. V. Scheltema, on behalf of the European Association of Urology‐Young Academic Urologists (EAU‐YAU) Prostate Cancer Working Group   +31 more
wiley   +1 more source

The first United States prospective trial using the Hugo™ robot‐assisted surgery system

BJU International, Volume 138, Issue 1, Page 85-91, July 2026.
Objective To describe the safety and effectiveness of the Hugo™ robot‐assisted surgery (RAS) system (Medtronic, Minneapolis, MN, USA) when used for three urological procedures. Patients and Methods The Expand URO (ClinicalTrials.gov identifier: NCT05696444) was the first investigational study for the Hugo RAS system based in the United States. It was a
Michael R. Abern, Peter Wiklund, Alvin C. Goh, Jihad H. Kaouk, Simone Crivellaro, Clayton S. Lau, Ali A. Zhumkhawala, Rogerio Huang, Reza Mehrazin, John P. Sfakianos, Ikenna Madueke, Brant A. Inman, Casey Blaser, Michele Masters, James R. Porter   +14 more
wiley   +1 more source

Genetic Predictors of Progression and Skin Rash in Japanese mCSPC Patients Treated With Apalutamide: CUARTET Study

Cancer Science, Volume 117, Issue 7, Page 1985-1995, July 2026.
In patients with mCSPC treated with apalutamide plus ADT, baseline ctDNA predicted earlier progression to CRPC and worse overall survival. Exploratory genome‐wide analysis identified 12 SNPs associated with apalutamide‐related skin rash. ABSTRACT Despite promising evidence of the efficacy of the androgen deprivation therapy (ADT) plus apalutamide in ...
Masaki Shiota, Taku Naiki, Koji Hatano, Akira Yokomizo, Hiroaki Tsuchiya, Yoko Takahashi, Taku Nakayama, Masaki Yoshida, Hirotsugu Uemura   +8 more
wiley   +1 more source

Real‐World Long‐Term Outcomes of Rezūm Therapy for Large‐Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study

LUTS: Lower Urinary Tract Symptoms, Volume 18, Issue 4, July 2026.
ABSTRACT Objectives Benign prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms (LUTS) in aging men. Patients with large prostates (≥ 80 mL) often experience more severe symptoms and have limited minimally invasive treatment options.
Liberty Liu, Mario Henrique Bitar Siqueira, Naeem Bhojani, Bilal Chughtai, Kevin C. Zorn, Luca Cindolo, Giovanni Ferrari, Katherine Lajkosz, Eviatar Fields, Dean Elterman   +9 more
wiley   +1 more source

Radical Prostatectomy [PDF]

Journal of the Korean Medical Association, 2004
openaire   +1 more source

Radical Prostatectomy [PDF]

, 2020
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Laparoscopic radical prostatectomy

World Journal of Urology, 2000
Laparoscopic radical retropubic prostatectomy (LRRP) is a new technique for treating organ-confined prostate carcinoma. The procedure was first described and proven to be feasible in 1997. To date, the results from over 150 cases have been reported in the literature.
P G, Schulam, R E, Link
openaire   +4 more sources

Laparoscopic Radical Prostatectomy

Journal of Endourology, 2004
Laparoscopic radical prostatectomy is a relatively new approach to the surgical treatment of localized prostate cancer. Since its inception, the technique, however challenging, is undergoing continuous refinements which make it today a feasible, reproducible, and teachable operation practiced by urologists worldwide.
A Karim, Touijer, Bertrand, Guillonneau
openaire   +4 more sources

Salvage radical prostatectomy

Current Opinion in Urology, 2022
Purpose of review Salvage radical prostatectomy (sRP) is underutilized because of fear of historical high rates of peri-operative morbidities. However, there has been significant improvements in complication rates as well as oncologic outcomes in the recent years.
Reza, Nabavizadeh, R Jeffrey, Karnes
openaire   +2 more sources

Radical prostatectomy.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2007
The management of prostate cancer is one of the core tasks for urologists today. Radical prostatectomy represents a valid therapeutic option for the curative treatment of localised prostate cancer. Urologists are on a continuous search for development of technical modifications and refinements, to reduce morbidity and ameliorate clinical and quality of
Sogni F, Terrone C
openaire   +4 more sources